Network-based integrative multi-omics approach reveals biosignatures
specific to COVID-19 disease phases
Mild data-driven approach
Mild hypothesis-driven approach
Moderate data-driven approach
Moderate hypothesis-driven approach
Severe data-driven approach
Severe hypothesis-driven approach